EdgarLookup

Xylem Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Xylem Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
10.6%
Profit Margin
Net income ÷ revenue
5.4%
Return on Assets
Net income ÷ assets
0.51x
Debt-to-Equity
Total liabilities ÷ equity
+5.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.04B Feb 25, 2026
FY2025 Dec 31, 2024 $8.56B Feb 25, 2026
FY2025 Dec 31, 2023 $7.36B Feb 25, 2026
FY2024 Dec 31, 2022 $5.52B Mar 3, 2025
FY2023 Dec 31, 2021 $5.20B Feb 28, 2024
FY2020 Dec 31, 2020 $1.37B Feb 26, 2021
FY2020 Sep 30, 2020 $1.22B Feb 26, 2021
FY2020 Jun 30, 2020 $1.16B Feb 26, 2021
FY2020 Mar 31, 2020 $1.12B Feb 26, 2021
FY2020 Dec 31, 2019 $1.37B Feb 26, 2021

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.04B Feb 25, 2026
FY2025 Dec 31, 2024 $8.56B Feb 25, 2026
FY2025 Dec 31, 2023 $7.36B Feb 25, 2026
FY2024 Dec 31, 2022 $5.52B Mar 3, 2025
FY2023 Dec 31, 2021 $5.20B Feb 28, 2024

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $1.28B Feb 23, 2018
FY2017 Sep 30, 2017 $1.20B Feb 23, 2018
FY2017 Jun 30, 2017 $1.16B Feb 23, 2018
FY2017 Mar 31, 2017 $1.07B Feb 23, 2018
FY2017 Dec 31, 2016 $1.10B Feb 23, 2018
FY2017 Sep 30, 2016 $897.00M Feb 23, 2018
FY2017 Jun 30, 2016 $932.00M Feb 23, 2018
FY2017 Mar 31, 2016 $847.00M Feb 23, 2018
FY2016 Dec 31, 2015 $994.00M Feb 23, 2017
FY2016 Sep 30, 2015 $902.00M Feb 23, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $957.00M Feb 25, 2026
FY2025 Dec 31, 2024 $890.00M Feb 25, 2026
FY2025 Dec 31, 2023 $609.00M Feb 25, 2026
FY2024 Dec 31, 2022 $355.00M Mar 3, 2025
FY2023 Dec 31, 2021 $427.00M Feb 28, 2024
FY2020 Dec 31, 2020 $148.00M Feb 26, 2021
FY2020 Sep 30, 2020 $37.00M Feb 26, 2021
FY2020 Jun 30, 2020 $31.00M Feb 26, 2021
FY2020 Mar 31, 2020 $38.00M Feb 26, 2021
FY2020 Dec 31, 2019 $118.00M Feb 26, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.22B Feb 25, 2026
FY2025 Dec 31, 2024 $1.01B Feb 25, 2026
FY2025 Dec 31, 2023 $652.00M Feb 25, 2026
FY2024 Dec 31, 2022 $622.00M Mar 3, 2025
FY2023 Dec 31, 2021 $585.00M Feb 28, 2024
FY2020 Dec 31, 2020 $179.00M Feb 26, 2021
FY2020 Sep 30, 2020 $73.00M Feb 26, 2021
FY2020 Jun 30, 2020 $54.00M Feb 26, 2021
FY2020 Mar 31, 2020 $61.00M Feb 26, 2021
FY2020 Dec 31, 2019 $195.00M Feb 26, 2021

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $17.63B Feb 25, 2026
FY2025 Dec 31, 2024 $16.49B Feb 25, 2026
FY2024 Dec 31, 2023 $16.11B Mar 3, 2025
FY2023 Dec 31, 2022 $7.95B Feb 28, 2024
FY2022 Dec 31, 2021 $8.28B Feb 24, 2023
FY2022 Dec 31, 2020 $8.75B Feb 24, 2023
FY2021 Dec 31, 2019 $7.71B Feb 25, 2022
FY2020 Dec 31, 2018 $7.22B Feb 26, 2021
FY2019 Dec 31, 2017 $6.86B Feb 28, 2020
FY2018 Dec 31, 2016 $6.47B Feb 22, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.89B Feb 25, 2026
FY2025 Dec 31, 2024 $5.61B Feb 25, 2026
FY2024 Dec 31, 2023 $5.94B Mar 3, 2025
FY2023 Dec 31, 2022 $4.45B Feb 28, 2024
FY2022 Dec 31, 2021 $5.05B Feb 24, 2023
FY2021 Dec 31, 2020 $5.77B Feb 25, 2022
FY2020 Dec 31, 2019 $4.74B Feb 26, 2021
FY2019 Dec 31, 2018 $4.44B Feb 28, 2020
FY2018 Dec 31, 2017 $4.34B Feb 22, 2019
FY2017 Dec 31, 2016 $4.27B Feb 23, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.48B Feb 25, 2026
FY2025 Dec 31, 2024 $10.64B Feb 25, 2026
FY2024 Dec 31, 2023 $10.17B Mar 3, 2025
FY2023 Dec 31, 2022 $3.49B Feb 28, 2024
FY2022 Dec 31, 2021 $3.22B Feb 24, 2023
FY2021 Dec 31, 2020 $2.97B Feb 25, 2022
FY2020 Dec 31, 2019 $2.96B Feb 26, 2021
FY2019 Dec 31, 2018 $2.77B Feb 28, 2020
FY2018 Dec 31, 2017 $2.50B Feb 22, 2019
FY2017 Dec 31, 2016 $2.19B Feb 23, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 25, 2026
FY2025 Dec 31, 2024 3 Feb 25, 2026
FY2025 Dec 31, 2023 2 Feb 25, 2026
FY2024 Dec 31, 2022 1 Mar 3, 2025
FY2023 Dec 31, 2021 2 Feb 28, 2024
FY2020 Dec 31, 2020 0 Feb 26, 2021
FY2020 Sep 30, 2020 0 Feb 26, 2021
FY2020 Jun 30, 2020 0 Feb 26, 2021
FY2020 Mar 31, 2020 0 Feb 26, 2021
FY2020 Dec 31, 2019 0 Feb 26, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 25, 2026
FY2025 Dec 31, 2024 3 Feb 25, 2026
FY2025 Dec 31, 2023 2 Feb 25, 2026
FY2024 Dec 31, 2022 1 Mar 3, 2025
FY2023 Dec 31, 2021 2 Feb 28, 2024
FY2020 Dec 31, 2020 0 Feb 26, 2021
FY2020 Sep 30, 2020 0 Feb 26, 2021
FY2020 Jun 30, 2020 0 Feb 26, 2021
FY2020 Mar 31, 2020 0 Feb 26, 2021
FY2020 Dec 31, 2019 0 Feb 26, 2021

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.48B Feb 25, 2026
FY2025 Dec 31, 2024 $1.12B Feb 25, 2026
FY2024 Dec 31, 2023 $1.02B Mar 3, 2025
FY2023 Dec 31, 2022 $944.00M Feb 28, 2024
FY2022 Dec 31, 2021 $1.35B Feb 24, 2023
FY2021 Dec 31, 2020 $1.88B Feb 25, 2022
FY2021 Dec 31, 2019 $724.00M Feb 25, 2022
FY2021 Dec 31, 2018 $296.00M Feb 25, 2022
FY2020 Dec 31, 2017 $414.00M Feb 26, 2021
FY2019 Dec 31, 2016 $308.00M Feb 28, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.95B Feb 25, 2026
FY2024 Dec 31, 2024 $2.03B Mar 3, 2025
FY2012 Dec 31, 2012 $1.21B Feb 25, 2013
FY2012 Dec 31, 2011 $1.21B Feb 25, 2013